ISAM 2026 Congress Program
Program Overview
ISAM 2026 is proudly endorsed and supported by:
ISAM 2026 Congress Schedule Overview
Monday 13 July 2026
8:00 - 9:00
Registration Open
9:00 - 12:30
Workshops
Workshop 1: Foundations and Advances in Respiratory Drug Delivery
Chairs
Speakers
Wei-Ren Ke Basics of respiratory drug delivery: physical principles of aerosol drug deposition (in vitro)
Jie Li Aerosol devices: comparison of functional principles and design elements
Arzu Ari Pediatric consideration: device selection and integration of device to patient
Jim Fink In Vitro–In Vivo Translation and Aerosol Performance
Kim Chan Inhaled Bacteriophage Therapy
Workshop 2: Inhaled Biologics – Development, Manufacturing and Regulatory Perspectives
Chair
Speakers
David Cipolla The Beginning of Inhaled Biologics
Gur Jal Pal Singh Regulatory Gaps Influencing the Development of Inhaled Biologics Therapeutics
Irene Rossi Enabling Respiratory Delivery of Nucleic Acids: A Lipid Nanoparticles Manufacturing Assessment
Lucas Silva Compatibility and performance assessment of biological molecules with nasal and pulmonary devices
Robert Tarran ELD615, a first-in-class inhaled Orai1 degrader for the treatment of chronic lung disease
Philippe Rogueda Looking at the horizon - Inhaled therapies in development
Valentina Sala Inhaled peptides: from field challenges to clinical reality in KIT2014 program
12:30 - 1:30
Lunch & Networking Group Meetings
1:30 - 2:00
Conference Opening
2:00 - 3:15
Session 1: Latest Clinical Insights in Pulmonary Science
Chairs
Ying Huang Tsai
Monbi Chakma
Speakers
Arzu Yorgancioğlu GINA 2026 update
Meng-Jer Hsieh Do extra‑fine particles drive the observed effects? Real‑world evidence comparing two ICS/LABA inhalers in patients with asthma.
Hsia-Lin Chen Treatment of neonatal respiratory distress in premature infants by inhaled exogenous surfactant: a pilot study
3:15 - 4:15
Social Break / Exhibitor Hall
4:15 - 5:30
Session 2: New Devices, Emerging Therapies and e-Health
Chair
Speakers
Sabine Häussermann Smart tools to enhance lung deposition of daily inhaled therapy at home
Arzu Ari Digital health in aerosol drug delivery: innovations, evidence, and patient impact
Gabriella Costabile Advancing siRNA Delivery to the Lung for Severe Pulmonary Diseases: The Role of Lipid–Polymer Hybrid Nanoparticles.
5:30 - 7:30
Reception with Local Drinks & Delicacies; Young Investigator Gathering
Tuesday 14 July 2026
8:00 - 9:00
Registration Open
9:00 - 9:30
Plenary Lecture
9:30 - 10:45
Session 3: Congress Chair’s Session
Chair
David Cipolla
Hui-Ling Lin
Speakers
Liang-Wen Hang Inhaled Therapies in Pulmonary Fibrosis: Clinical Evidence and Delivery Considerations
Satomi Onoue Formulation approaches to overcome biopharmaceutical limitations of inhaled drugs
Jann-Yuan Wang Current challenges in the treatment of nontuberculous mycobacterial lung disease
10:45 - 11:30
Coffee Break / Exhibitor Hall
11:30 - 12:45
Flash Talks
Networking Groups: New Devices and Imaging
12:45 - 2:00
Lunch & Networking Group Meeting
2:00 - 3:15
Flash Talks
Networking Groups: Clinical and Toxicology
3:15 - 4:15
Social Break & Chaired Poster Session
4:15 - 5:30
Session 4: Inhalation Toxicology
Chair
Speakers
Barbara Rothen-Rutishauser Transport-related air pollution: effects in the lung and beyond
Yuanpu Peter Di The lung as a gateway to human health: the dynamic balance of inhaled exposures, the microbiome, and therapeutic response
Hsiao-Chi Chuang Air pollution and emphysema: pathogenic mechanisms and clinical implications
5:30 - 7:30
Reception with Local Drinks & Delicacies
Wednesday 15 July 2026
8:00 - 9:00
Registration Open
9:00 - 9:30
Plenary Lecture
9:30 - 10:45
Session 5: Imaging, Modelling, and Physiology
Chairs
Chantal Darquenne
Ulf Krüger
Speakers
Armele Dornelas de Andrade Post-COVID Respiratory Impairments: Imaging, Functional Outcomes, and Therapeutic Advances
Chang Gyu Woo In vitro lung MPS: a new ensemble model for preclinical studies
Francesca Buttini High-dose administration of engineered antibiotic powder via orbital inhaler and simulation of lung deposition
10:45 - 11:30
Coffee Break / Exhibitor Hall
11:30 - 12:45
Session 6: Best Oral Presentations
12:45 - 2:00
Lunch & Networking Group Meeting
2:00 - 3:15
Flash Talks
Networking Groups: Formulations and Regulatory
3:15 - 4:15
Social Break & Chaired Poster Session
4:15 - 4:30
Award Ceremony: Best Oral and Poster Presentations
6:30 - 9:00
Gala Dinner at the Grand Hotel
Thursday 16 July 2026
8:00 - 9:00
Registration Open
9:00 - 9:30
Plenary Lecture
9:30 - 10:45
Session 7: Regulatory and Standardization
Chair
Speakers
Ta-Chih Hsiao The 10 nm regulatory gap in UFP monitoring and its impact on lung-deposited surface area health risk assessment
Bryan Newman Regulatory challenges from a bioequivalence perspective
Ross Walenga Fostering generic orally inhaled drug products in the United States: regional deposition modeling as model-integrated evidence
10:45 - 11:30
Coffee Break / Exhibitor Hall
11:30 - 12:45
Session 8: Formulation of OINDP
Chairs
Speakers
Kin Hang Kok A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
Teerapol Srichana Novel approaches for the treatment of pulmonary tuberculosis
Philip Kwok Inhalable cannabidiol powders with enhanced solubility
12:45
Close of Congress
We gratefully acknowledge the generous support of our confirmed ISAM 2026 sponsors.
Platinum Sponsor
Gold Sponsor
Silver Sponsors
Bronze Sponsors
Further Sponsors & Exhibitors
